Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Early monitoring of anti-infliximab antibodies by drug-tolerant assay predicts later immunogenicity and drug survival in rheumatic diseases.
Martínez-Feito A, Novella-Navarro M, Hernández-Breijo B, Nozal P, Peiteado D, Villalba A, Nuño L, Monjo I, Pascual-Salcedo D, Balsa A, Plasencia-Rodríguez C. Martínez-Feito A, et al. Among authors: monjo i. Rheumatology (Oxford). 2024 Jan 4:kead690. doi: 10.1093/rheumatology/kead690. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38175741
Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
De Miguel E, Karalilova R, Macchioni P, Ponte C, Conticini E, Cowley S, Tomelleri A, Monti S, Monjo I, Batalov Z, Klinowski G, Falsetti P, Kane DJ, Campochiaro C, Hočevar A. De Miguel E, et al. Among authors: monjo i. Ann Rheum Dis. 2024 Feb 15;83(3):335-341. doi: 10.1136/ard-2023-224768. Ann Rheum Dis. 2024. PMID: 37932008
Patient and physician assessment in difficult-to-treat rheumatoid arthritis: patterns of subjective perception at early stages of b/tsDMARD treatment.
Novella-Navarro M, Cabrera-Alarcón J, López-Juanes N, Villalba A, Fernández Fernández E, Monjo I, Peiteado D, Nuño L, Plasencia-Rodríguez C, Balsa A. Novella-Navarro M, et al. Among authors: monjo i. RMD Open. 2023 Sep;9(3):e003382. doi: 10.1136/rmdopen-2023-003382. RMD Open. 2023. PMID: 37775112 Free PMC article.
Immune response after SARS-CoV-2 vaccination in patients with inflammatory immune-mediated diseases receiving immunosuppressive treatment.
Plasencia-Rodríguez C, Martínez-Feito A, Hernández M, Del Pino-Molina L, Novella-Navarro M, Serrano Y, González-Muñoz M, Peiteado D, Bonilla G, Monjo I, Nuño L, Tornero C, López-Granados E, Balsa A, Nozal P. Plasencia-Rodríguez C, et al. Among authors: monjo i. Allergy Asthma Clin Immunol. 2023 Aug 19;19(1):71. doi: 10.1186/s13223-023-00832-0. Allergy Asthma Clin Immunol. 2023. PMID: 37598192 Free PMC article.
A paradigm of difficult-to-treat rheumatoid arthritis: subtypes and early identification.
Novella-Navarro M, Ruiz-Esquide V, Torres-Ortiz G, Chacur CA, Tornero C, Fernández-Fernández E, Monjo I, Sanmartí R, Plasencia-Rodríguez C, Balsa A. Novella-Navarro M, et al. Among authors: monjo i. Clin Exp Rheumatol. 2023 May;41(5):1114-1119. doi: 10.55563/clinexprheumatol/7mscci. Epub 2022 Nov 13. Clin Exp Rheumatol. 2023. PMID: 36377568 Free article.
Achievement rate and predictive factors of the recommended therapeutical target in patients with axial spondyloarthritis who remain on biological therapy: a prospective cohort study in Spain.
Benavent D, Franco-Gómez K, Plasencia-Rodriguez C, Novella-Navarro M, Bogas P, Nieto R, Monjo I, Nuño L, Villalba A, Peiteado D, Balsa A, Navarro-Compán V. Benavent D, et al. Among authors: monjo i. BMJ Open. 2022 Apr 29;12(4):e057850. doi: 10.1136/bmjopen-2021-057850. BMJ Open. 2022. PMID: 35487753 Free PMC article.
Obesity and response to biological therapy in rheumatoid arthritis: the role of body mass index and adipose tissue cytokines.
Novella-Navarro M, Genre F, Hernández-Breijo B, Remuzgo-Martínez S, Martínez-Feito A, Peiteado D, Monjo I, González-Gay MÁ, Plasencia-Rodríguez C, Balsa A. Novella-Navarro M, et al. Among authors: monjo i. Clin Exp Rheumatol. 2022 Sep;40(9):1726-1732. doi: 10.55563/clinexprheumatol/a9gskx. Epub 2022 Jan 12. Clin Exp Rheumatol. 2022. PMID: 35084302 Free article.
Early monitoring of infliximab serum trough levels predicts long-term therapy failure in patients with axial spondyloarthritis.
Martínez-Feito A, Navarro-Compán V, Hernández-Breijo B, Olariaga-Mérida E, Peiteado D, Villalba A, Nuño L, Monjo I, Diego C, Pascual-Salcedo D, Nozal P, Balsa A, Plasencia-Rodríguez C. Martínez-Feito A, et al. Among authors: monjo i. Scand J Rheumatol. 2022 Mar;51(2):102-109. doi: 10.1080/03009742.2021.1914430. Epub 2021 Jun 29. Scand J Rheumatol. 2022. PMID: 34182885
21 results